323 related articles for article (PubMed ID: 37365028)
21. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
[TBL] [Abstract][Full Text] [Related]
22. Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
Wei Y; Lan C; Yang C; Liao X; Zhou X; Huang X; Xie H; Zhu G; Peng T
Sci Rep; 2023 Sep; 13(1):14519. PubMed ID: 37666920
[TBL] [Abstract][Full Text] [Related]
23. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma.
Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L
Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899
[TBL] [Abstract][Full Text] [Related]
24. Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma.
Tian S; Liu J; Sun K; Liu Y; Yu J; Ma S; Zhang M; Jia G; Zhou X; Shang Y; Han Y
Front Oncol; 2020; 10():597996. PubMed ID: 33575212
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients.
Liu Y; Shen B; Huang T; Wang J; Jiang J
PLoS One; 2023; 18(7):e0288013. PubMed ID: 37406019
[TBL] [Abstract][Full Text] [Related]
26. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
Li Y; Zeng X
Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
[No Abstract] [Full Text] [Related]
27. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
Xiao Y; Li J; Wu J
BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
[TBL] [Abstract][Full Text] [Related]
28. Elevated expression of TNFRSF4 impacts immune cell infiltration and gene mutation in hepatocellular carcinoma.
Wang D; Hu H; Ding H; Zhao H; Tian F; Chi Q
Cancer Biomark; 2023; 36(2):147-159. PubMed ID: 36591653
[TBL] [Abstract][Full Text] [Related]
29. Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma.
Fang Q; Chen H
Front Oncol; 2020; 10():591356. PubMed ID: 33392087
[TBL] [Abstract][Full Text] [Related]
30. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
[TBL] [Abstract][Full Text] [Related]
31. Establishment of an endoplasmic reticulum stress-associated lncRNAs model to predict prognosis and immunological characteristics in hepatocellular carcinoma.
Shen X; Wu S; Yang Z; Zhu C
PLoS One; 2023; 18(8):e0287724. PubMed ID: 37647290
[TBL] [Abstract][Full Text] [Related]
32. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma.
Huang R; Chen Z; Li W; Fan C; Liu J
Int J Oncol; 2020 May; 56(5):1199-1211. PubMed ID: 32319580
[TBL] [Abstract][Full Text] [Related]
33. Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method.
Yu Z; Shi FE; Mao Y; Song A; He L; Gao M; Wei H; Xiao F; Wei H
Medicine (Baltimore); 2023 Jul; 102(29):e34367. PubMed ID: 37478222
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
Yang C; Zhang L; Hao X; Tang M; Zhou B; Hou J
Curr Oncol; 2022 Dec; 30(1):430-448. PubMed ID: 36661684
[TBL] [Abstract][Full Text] [Related]
35. Construction and validation of a prognostic model based on autophagy-related genes for hepatocellular carcinoma in the Asian population.
Wang Y; Huang S; Zhang Y; Cheng Y; Dai L; Gao W; Feng Z; Tao J; Zhang Y
BMC Genomics; 2023 Jun; 24(1):357. PubMed ID: 37370041
[TBL] [Abstract][Full Text] [Related]
36. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
37. An aging-related gene signature to predict the prognosis of hepatocellular carcinoma.
Fang Y; Yang W; Wu L; Yao L; Cao X; Chen H
Medicine (Baltimore); 2023 Dec; 102(51):e36715. PubMed ID: 38134103
[TBL] [Abstract][Full Text] [Related]
38. Expression of pyroptosis-associated genes and construction of prognostic model for thyroid cancer.
Guo L; Yuan M; Jiang S; Jin G; Li P
Transl Cancer Res; 2023 Dec; 12(12):3360-3383. PubMed ID: 38193001
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of a prognostic-related mutant gene
Song Z; Song X; Li H; Cheng Z; Mo Z; Yang X
Front Immunol; 2023; 14():1236995. PubMed ID: 38022557
[TBL] [Abstract][Full Text] [Related]
40. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients.
Qu J; Tao D; Huang W; Lu L; Fan J; Zhang S; Huang F
Heliyon; 2023 Aug; 9(8):e18493. PubMed ID: 37520979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
